There seems to be a lot of angst these days over the U.S. patent system. Generally, complaints come from those who feel they can’t do whatever it is they want to do and they want new rules. Now, the Council on Foreign Relations has released a study, entitled “Reforming the U.S. Patent System: Getting the […]
When I did my Master’s thesis, I studied endocrine physiology in rats. Lots and lots of rats. Hence, I spent many a day preserving and fixing tissue samples and sitting at a microtome cutting slices of tissue for mounting on slides for staining. So, I felt a real affection for the recent patent case of […]
Eli Lilly & Co. had its patent on Zyprexa®, the world’s top- selling schizophrenia drug, upheld by the Court of Appeals for the Federal Circuit. The court affirmed a lower court decision that the patent is valid stating that for a chemical compound, a prima facie case of obviousness requires “structural similarity between claimed and […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
